![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsors and Collaborators: |
National Center for Research Resources (NCRR) University of Washington |
---|---|
Information provided by: | National Center for Research Resources (NCRR) |
ClinicalTrials.gov Identifier: | NCT00004342 |
OBJECTIVES: I. Document the clinical course of severe chronic neutropenia (SCN).
II. Monitor and assess long term safety of primary treatment in SCN patients in the United States, Canada, Europe, and Australia.
III. Study the incidence and outcome of adverse events such as osteoporosis, splenomegaly, cytogenetic abnormalities, myelodysplastic syndrome, and leukemia.
IV. Evaluate growth and development and hematologic parameters. V. Monitor for clinically significant changes in primary treatment response over time.
VI. Establish a physician network to increase the understanding of SCN. VII. Establish a demographic database to allow for future research.
Condition |
---|
Neutropenia |
Study Type: | Observational |
Study Design: | Natural History |
Ages Eligible for Study: | 3 Months and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
PROTOCOL ENTRY CRITERIA:
--Disease Characteristics-- Severe chronic neutropenia (SCN), i.e.: Absolute neutrophil count less than 500/mm3 on 3 occasions within the last 3 months (less than 200/mm3 for cyclic neutropenia) Bone marrow aspirate consistent with SCN History of infection No drug induced neutropenia No myelodysplastic syndrome No aplastic anemia No thrombocytopenia or anemia unless due to Shwachman-Diamond syndrome or glycogen storage disease type IB Prior enrollment on Amgen SCN trials eligible Bone marrow aspiration within 1 year required Cytogenetic evaluation strongly suggested --Prior/Concurrent Therapy-- At least 5 years since prior chemotherapy --Patient Characteristics-- No rheumatoid arthritis No systemic lupus erythematosus No HIV seropositivity
United States, Michigan | |
Women's Hospital | Recruiting |
Ann Arbor, Michigan, United States, 48109-0266 | |
Contact: Laurence A. Boxer 734-764-7127 | |
United States, New Jersey | |
St. Barnabas Medical Center | Recruiting |
Livingston, New Jersey, United States, 07039 | |
Contact: Donna Mura 973-322-8076 dmura@sbhcs.com | |
United States, Washington | |
University of Washington School of Medicine | Recruiting |
Seattle, Washington, United States, 98195 | |
Contact: David Chandler Dale 206-543-7215 | |
Australia, Victoria | |
Central Highlands Oncology Program | Recruiting |
Ballarat, Victoria, Australia, 3350 | |
Contact: George Kannourakis 61-353-334811 | |
Canada, Manitoba | |
CancerCare Manitoba | Recruiting |
Winnipeg, Manitoba, Canada, R3E 0V9 | |
Contact: Bonnie Paula Cham 204-787-4147 | |
Canada, Ontario | |
Hospital for Sick Children | Recruiting |
Toronto, Ontario, Canada, M5G 1X8 | |
Contact: Melvin H. Freedman 416-813-6152 | |
Germany | |
Medizinische Hochschule Hannover | Recruiting |
Hannover, Germany, D-30625 | |
Contact: Karl Welte 0511-532-6710 | |
Italy | |
Istituto Giannina Gaslini | Recruiting |
Genova, Italy, 16148 | |
Contact: Pier G. Mori 10-5636-331 | |
United Kingdom, England | |
St. James's Hospital | Recruiting |
Leeds, England, United Kingdom, LS9 7TF | |
Contact: Sally Kinsey 113 243 31 44 |
Study Chair: | David Chandler Dale | University of Washington |
Study ID Numbers: | 199/11901, UW-730 |
Study First Received: | October 18, 1999 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00004342 |
Health Authority: | United States: Federal Government |
chronic neutropenia disease-related problem/condition hematologic disorders |
neutropenia rare disease severe chronic neutropenia |
Neutropenia Hematologic Diseases Agranulocytosis Rare Diseases |
Chronic neutropenia Leukocyte Disorders Leukopenia Granulocytopenia |